Pembrolizumab After ASCT for Hodgkin Lymphoma, DLBCL and T-NHL
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Mayo Clinic
Amgen
Celldex Therapeutics
National Institutes of Health Clinical Center (CC)
Sunnybrook Health Sciences Centre
Novartis
Merck Sharp & Dohme LLC
University of Washington
Ohio State University Comprehensive Cancer Center